MedPath

Immature Myeloid Cells in Respiratory Syncytial Virus Bronchioliltis

Conditions
Bronchiolitis
Interventions
Other: Respiratory secretions obtained
Registration Number
NCT01684527
Lead Sponsor
Hillel Yaffe Medical Center
Brief Summary

The investigators hypothesize that Respiratory Syncytial Virus (RSV) infection may influence the population of lung immature myeloid cells and dendritic cells in a way that will impair their ability to invoke an effective immune response and lead to prolonged inflammation, angiogenesis and scarring. This may lead in turn to disturbed lung function.

Our aim is to determine the presence and phenotype of immature myeloid cells present in respiratory secretions of children with RSV bronchiolitis as compared to non-RSV bronchiolitis and healthy controls.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
55
Inclusion Criteria
  • Bronchiolitis
Exclusion Criteria
  • Chronic disease

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Children Suffering From BronchiolitisRespiratory secretions obtainedRespiratory secretions obtained from children suffering from Bronchiolitis
Healthy ChildrenRespiratory secretions obtainedRespiratory secretions obtained from children with no respiratory infection
Primary Outcome Measures
NameTimeMethod
Number of Immature Myeloid Cells in Respiratory SecretionsParticipants will be followed for the duration of hospital stay, an expected average of one week

Respiratory secretions obtained from child presenting with bronchiolitis will be examined for the presence of immature myeloid cells

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hillel Yaffe Medical Center

🇮🇱

Hadera, Israel

© Copyright 2025. All Rights Reserved by MedPath